Our Blog

Kemwell Biopharma Facility in Bengaluru Successfully Completes U.S. FDA Inspection for Commercial Drug-Product Manufacturing

Business Wire release Milestone expands India’s role in global biologics manufacturing; collaboration with Cipla underscores commitment to quality…

Read More

Breaking Barriers: How Kemwell’s Mitigation Strategy Overcomes Viscosity-Induced High-Concentration TFF Challenges

Introduction: Recent advances in biologics development are primarily focussed on development of high titre producing cell lines to…

Read More

Kemwell’s Expertise in Size Exclusion Chromatography for Isoform Separation of a Novel Tri-specific Antibody

Introduction: Size variants determination is a critical quality attribute for a therapeutic recombinant antibody, since they can impact…

Read More

New at Kemwell

A collection of stories about our people, our capabilities, our research,
and the ever-changing face of our firm.

Uncategorized

Business Wire release Milestone expands India’s role in global biologics manufacturing;…

Read More
Case Study

Introduction: Recent advances in biologics development are primarily focussed on development…

Read More
Case Study

Introduction: Size variants determination is a critical quality attribute for a…

Read More

Get in Touch

Name(Required)